Fundraising Fox

ARCH Venture Partners vs OUP (Osage University Partners)

Two firms that co-invest: side by side on stage, sector, check size, and track record, from public filings and the firms' own sites.

ARCH Venture PartnersOUP (Osage University Partners)
TypeVenture capitalVenture capital
HQChicagoBala Cynwyd
Founded19892009
Check size$50K – $250M$1M – $20M
StagesSeed, Series A, Series B, Series C, GrowthPre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage
SectorsBiotech, Deep Tech, HealthtechAI & Machine Learning, Biotech, Cleantech, Climate Tech, Cloud Computing, Cybersecurity, Deep Tech, Digital Health, Energy, Enterprise Software, Hardware, Healthtech, Medical Devices, New Materials, Quantum Computing, SaaS, Sector Agnostic, Semiconductors
AUM$12B$800M
Tracked investments144118
Exits (acquired/public)61
Led rounds on record3β€”
Dated deals, last 24 mo103

Shared portfolio Β· 10

Beam TherapeuticseGenesisFaraday PharmaceuticalsKura OncologyPrime MedicineQuantum CircuitsReceptosSana BiotechnologySonoma BiotherapeuticsHomology Medicines

Frequently asked questions

Do ARCH Venture Partners and OUP (Osage University Partners) invest together?
Yes β€” ARCH Venture Partners and OUP (Osage University Partners) appear together in 10 tracked portfolio companies, including Beam Therapeutics, eGenesis, Faraday Pharmaceuticals, Kura Oncology, Prime Medicine.
How do ARCH Venture Partners and OUP (Osage University Partners) compare on check size?
ARCH Venture Partners typically writes checks of $50K – $250M, while OUP (Osage University Partners) writes $1M – $20M.